A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants
Saved in:
| Title: | A randomized, double-blind, placebo-controlled, phase 1/2a study of the safety and immunogenicity of a live, attenuated human parainfluenza virus type 3 vaccine in healthy infants |
|---|---|
| Authors: | Bernstein, David I.1 david.bernstein@cchmc.org, Falloon, Judith2 falloonj@medimmune.com, Yi, Tingting2 yit@medimmune.com |
| Source: | Vaccine. Sep2011, Vol. 29 Issue 40, p7042-7048. 7p. |
| Database: | Environment Complete |
Be the first to leave a comment!
